MedDevNews, Q2 2024
Medtech valuations decreased in Q2 2024, and while investments in the medical device sector have been under pressure since 2021, Q2 U.S. private financing trends indicate a promising path toward sustained growth. U.S. private financing exhibited a notable recovery, seeing a 10.2% increase from the previous quarter. The average amount of capital raised stood at $10.3 million, marking a substantial 70% surge from Q2 2023. Read the full report here.